Quantitative assessment of the transport of elastic and rigid vesicle components and a model drug from these vesicle formulations into human skin in vivo.

The aim of this study was to quantitatively assess the distribution profiles of elastic and rigid vesicle material in human skin in vivo. Furthermore, the distribution profiles of the model drug ketorolac applied in these vesicle formulations was investigated. A deuterium-labelled phospholipid was incorporated into these vesicles to serve as a marker for the vesicle material. The vesicles were loaded with ketorolac at saturated concentrations. Vesicle solutions were applied non-occlusively onto the skin and the treated site was sequentially tape-stripped. Tape-strips were analyzed for vesicle material using attenuated total reflectance-Fourier transform infrared spectroscopy and for ketorolac by extraction of the tape-strips followed by high pressure liquid chromatography. Distribution profiles in the stratum corneum (SC) were obtained for the elastic and rigid vesicle material and for the ketorolac. These profiles have suggested that elastic vesicle material can rapidly enter the deeper layers of the SC and can reach almost the SC-viable epidermal junction. Rigid vesicle material, however, did not penetrate deep into the SC. Furthermore, the elastic vesicles were better than the rigid vesicles in the enhancement of ketorolac transport into human SC. The distribution profile of ketorolac in the deeper SC layers was, however, different from that of the vesicle material. This suggests that once the elastic vesicles partition into the SC, the ketorolac is released from the vesicles. The elastic vesicles are superior to the rigid vesicles both in terms of vesicular transport into the SC and in terms of therapeutic potential as a skin delivery vehicle.

[1]  Johann W Wiechers,et al.  Water distribution and related morphology in human stratum corneum at different hydration levels. , 2003, The Journal of investigative dermatology.

[2]  R. Warner,et al.  Hydration disrupts human stratum corneum ultrastructure. , 2003, The Journal of investigative dermatology.

[3]  J. Bouwstra,et al.  The in vitro transport of pergolide from surfactant-based elastic vesicles through human skin: a suggested mechanism of action. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[4]  J. Bouwstra,et al.  The in vivo and in vitro interactions of elastic and rigid vesicles with human skin. , 2002, Biochimica et biophysica acta.

[5]  A. Schätzlein,et al.  Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurements. , 2002, Biochimica et biophysica acta.

[6]  H. Junginger,et al.  Transdermal Delivery of Pergolide from Surfactant-Based Elastic and Rigid Vesicles: Characterization and in Vitro Transport Studies , 2002, Pharmaceutical Research.

[7]  G. Cevc,et al.  New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, Transfersomes. , 2001, Biochimica et biophysica acta.

[8]  Adrian C. Williams,et al.  Skin delivery of 5‐fluorouracil from ultradeformable and standard liposomes in‐vitro , 2001, The Journal of pharmacy and pharmacology.

[9]  P. Wertz,et al.  Elasticity of vesicles assessed by electron spin resonance, electron microscopy and extrusion measurements. , 2001, International journal of pharmaceutics.

[10]  P. Wertz,et al.  Elasticity of vesicles affects hairless mouse skin structure and permeability. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[11]  H. Junginger,et al.  Interactions of elastic and rigid vesicles with human skin in vitro: electron microscopy and two-photon excitation microscopy. , 1999, Biochimica et biophysica acta.

[12]  Adrian C. Williams,et al.  Skin Delivery of Oestradiol from Deformable and Traditiona Liposomes: Mechanistic Studies , 1999, The Journal of pharmacy and pharmacology.

[13]  Andreas G. Schätzlein,et al.  Ultraflexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. , 1998, Biochimica et biophysica acta.

[14]  J. Domenech,et al.  A comparative study of the transdermal penetration of a series of nonsteroidal antiinflammatory drugs. , 1997, Journal of pharmaceutical sciences.

[15]  R H Guy,et al.  Homogeneous transport in a heterogeneous membrane: water diffusion across human stratum corneum in vivo. , 1996, Biophysical journal.

[16]  A. Naik,et al.  Validation of Reflectance Infrared Spectroscopy as a Quantitative Method to Measure Percutaneous Absorption In Vivo , 1993, Pharmaceutical Research.

[17]  G. Cevc,et al.  Noninvasive percutaneous induction of topical analgesia by a new type of drug carrier, and prolongation of local pain insensitivity by anesthetic liposomes. , 1992, Anesthesia and analgesia.

[18]  G. Cevc,et al.  Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. , 1992, Biochimica et biophysica acta.

[19]  A. Florence,et al.  The preparation and properties of niosomes—non‐ionic surfactant vesicles , 1985, The Journal of pharmacy and pharmacology.

[20]  H. Junginger,et al.  The effect of surfactant-based elastic and rigid vesicles on the penetration of lidocaine across human skin , 2002 .